Andrew Mataya retweeted
In our recent publication, we present new insights into the population genomics of Streptococcus mitis in UK and Ireland bloodstream infection and infective endocarditis cases..(1/8)
nature.com/articles/s41467-0…
Andrew Mataya retweeted
A positive development has come up regarding my visa costs. I’m pausing the GoFundMe. Please check the fundraiser page for details. I'll refund donations once everything is confirmed.
THANK YOU!!!❣️🌟Your support has been so encouraging - I look forward to paying it forward.
Hi. I have set up a GoFundMe to help cover costs of my work visa. While my university will reimburse me later, I need help to make my application.I promise to refund all donations
gofundme.com/f/me-secure-my-…
Any contribution or share with networks will be greatly appreciated!
Andrew Mataya retweeted
Hi. I have set up a GoFundMe to help cover costs of my work visa. While my university will reimburse me later, I need help to make my application.I promise to refund all donations
gofundme.com/f/me-secure-my-…
Any contribution or share with networks will be greatly appreciated!
Andrew Mataya retweeted
#AcademicTwitter
Writing (research) manuscripts is hard🥲
A few things that I wish I had learned earlier that would have made it easier:
1/8
Andrew Mataya retweeted
Replying to @AndrewAMataya
@AndrewAMataya Your second option is preferred: upper middle-income country. @ChicagoManual seems to bear this out as well (chapter 7.87 on hyphens). @worldbank also formats as "upper middle-income economies." However we've seen "upper-middle-income country" as well (2 hyphens).
Replying to @AMAManual
@AMAManual: "upper–middle-income country" or "upper middle-income country"? (Grammarly is putting red lines under both and is voting for "upper-middle-income".)
Andrew Mataya retweeted
De-listing such big a journal is clearly a sign.
And the sign says this: you *do* get a high IF, dead easy publication to add to your CV. But it might be worth nothing a few years down the line, when people stop believing in magic.
Andrew Mataya retweeted
Child had a CXR and it was noticed. We successfully removed it today.
#zimsurgeons
#womeninsurgery
#womenincardiothoracicsurgery
Andrew Mataya retweeted
Manuscript rejected after 3 months because the journal couldn’t find ONE single reviewer. I hear this is an increasingly common issue across journals.
Academics, if we’re not supporting each other to move our fields forward, what are we even doing?
@AcademicChatter
Andrew Mataya retweeted
The UN Open Science Conference 2023 starts today at 4pm CAT/5pm EAT/3pm WAT. Registration is free.
AJOL CEO Susan Murray will be addressing the conference as part of a panel on reforming scientific publishing tomorrow, 9 February, at 17:45 CAT.
un.org/en/library/OS23
Andrew Mataya retweeted
We're trying to raise money to help clear the severe backlog of ortho trauma patients here in Malawi before a new facility LION opens on April 28. 100+ patients can't wait that long. Just $400 can support us operating on the weekends. gofund.me/701c7ce2
Andrew Mataya retweeted
My nephew Yami hasn't been seen or heard from in a couple of days by his family. We will appreciate any information on his possible whereabouts. Please help us share this poster far and wide 🙏
Andrew Mataya retweeted
Replying to @vectorgen
But this idealized idea of what peer review gets you *is exactly the problem*. The eLife model is acknowledging that, and sharing reviews to help you place *this specific manuscript* rather than relying on the mean of its distribution
Andrew Mataya retweeted
Replying to @vectorgen
No the imprint for quality is what the reviews themselves say. eLife’s reviews will hopefully outcompete others because they will be consistently structured and follow specific guidelines.

























